Stockreport

neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis) [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF Pediatrix Therapeutics which has a license from ARS Pharma to market neffy in China under the trade name ??? ® , expects availability in the spring of 2026 SAN DIEGO, [Read more]